Jennifer J Westerhuis
Overview
Explore the profile of Jennifer J Westerhuis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kenyon E, Zaluzec E, Powell K, Volk M, Chakravarty S, Hix J, et al.
J Vis Exp
. 2022 Apr;
(182).
PMID: 35435915
Breast cancer is the most prevalent cancer and the second-leading cause of cancer-related death for women in the USA. For high-risk women, prophylactic mastectomy is the most effective primary prevention...
2.
Schipper J, Westerhuis J, Beddows I, Madaj Z, Monsma D, Hostetter G, et al.
Int J Cancer
. 2020 May;
147(8):2265-2278.
PMID: 32388866
The microenvironment of pancreatic cancer adenocarcinoma (PDAC) is highly desmoplastic with distinct tumor-restraining and tumor-promoting fibroblast subpopulations. Re-education rather than indiscriminate elimination of these fibroblasts has emerged as a new...
3.
Kenyon E, Westerhuis J, Volk M, Hix J, Chakravarty S, Claucherty E, et al.
Breast Cancer Res
. 2019 Nov;
21(1):129.
PMID: 31779648
Background: Prophylactic mastectomy is the most effective intervention to prevent breast cancer. However, this major surgery has life-changing consequences at the physical, emotional, psychological, and social levels. Therefore, only high-risk...
4.
Graveel C, Calderone H, Westerhuis J, Winn M, Sempere L
Breast Cancer (Dove Med Press)
. 2015 Mar;
7:59-79.
PMID: 25759599
Breast cancer is a complex and heterogeneous disease. Signaling by estrogen receptor (ER), progesterone receptor (PR), and/or human EGF-like receptor 2 (HER2) is a main driver in the development and...